Glooko Connected Diabetes Care Platform

Glooko, Inc. provides software for diabetes care teams and has been used by more than 4.4 million people according to its 2025 press release, which was issued from Palo Alto, California. It addresses fragmented diabetes data across devices, clinics and hospitals.

The platform lets clinicians review data across more than 200 compatible diabetes and health devices, including CGM, blood glucose meters and insulin pumps. Products include GlookoCare for ambulatory device-data review and population management, GlookoCare GestationalCare for diabetes in pregnancy, EndoTool for inpatient insulin dosing, and GlookoRWD for real-world data, with EHR-connected workflows and an API portal.

• Device data review: view data from more than 200 compatible diabetes and health devices.
• Ambulatory management: GlookoCare for population management and patient engagement.
• GestationalCare: shared workflow for diabetes in pregnancy with configured alerts.
• Inpatient dosing: EndoTool, an FDA-cleared Class II device for insulin dosing.
• EHR connection: EHR-connected workflows and an API and EHR integration portal.
• Real-world data: GlookoRWD for clinical research insights.

Endocrinology departments consolidating CGM and meter data for outpatient follow-up. Hospitals standardizing inpatient insulin dosing with EndoTool. Maternity clinics running a shared gestational diabetes workflow across obstetrics and endocrinology.

Care teams review data from CGM, meters and pumps in one place instead of separate device portals. EHR-connected workflows are designed to reduce portal and documentation burden. Population views help prioritize which patients need review first. EndoTool supports guideline-aligned insulin dosing for hospitalized patients.

Diabetes care is shifting toward CGM-based decisions, which creates data volume that clinics must review across many device brands. Vietnam and Southeast Asia have a large and growing diabetes population, and hospitals there are looking for ways to manage glucose data between visits and in inpatient wards.

Glooko, Inc. acquired Monarch Medical Technologies, maker of EndoTool, in September 2025. The website lists a 2026 MedTech Breakthrough Awards win for Best Overall MedTech Software (undated) and a partnership with mylife Diabetes Care. Founding year and headquarters are not stated on the fetched pages.